The Food and Drug Administration is expected to decide by Dec. 8 on a new therapy to treat sickle cell disease using gene editing technology called CRISPR, which stands for clustered regularly ...

Two experts joined "In Focus" to explain gene editing therapy for sickle cell disease. Cassandra Dobson and Dr. Thomas Moulton explained how CRISPR gene editing works and shared the cost of the ...

Dr Rosemary Byanyima, the Executive Director of Mulago National Referral Hospital, said health workers continue to witness ...

The U.S. Food and Drug Administration on Friday approved two gene-based treatments for sickle cell disease, including the first therapy that uses the gene-editing technique CRISPR, opening a new era ...

For sickle cell, patients’ cells are removed from the body and CRISPR is used to make an edit that turns back on production of fetal hemoglobin, a form of the protein that babies make in the womb.

Scientists had tried to treat diseases by editing genes since the 1990s, but the methods were cumbersome and didn’t pay off. Then in June 2012, the journal Science published a paper by two future ...

According to him, most messaging focuses on knowing one’s genotype but does not address the complex social, emotional, and ...

The 33rd annual walkathon for the Northeast Louisiana Sickle Cell anemia Foundation is scheduled for this Saturday at the ...

(CNN) — The US Food and Drug Administration on Friday approved two gene-based treatments for sickle cell disease, including the first therapy that uses the gene-editing technique CRISPR, opening a new ...